398 related articles for article (PubMed ID: 16933094)
1. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition.
Bhugra C; Shmeis R; Krill SL; Pikal MJ
Pharm Res; 2006 Oct; 23(10):2277-90. PubMed ID: 16933094
[TBL] [Abstract][Full Text] [Related]
2. Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times.
Bhugra C; Shmeis R; Krill SL; Pikal MJ
J Pharm Sci; 2008 Jan; 97(1):455-72. PubMed ID: 17854050
[TBL] [Abstract][Full Text] [Related]
3. Different measures of molecular mobility: comparison between calorimetric and thermally stimulated current relaxation times below Tg and correlation with dielectric relaxation times above Tg.
Bhugra C; Shmeis R; Krill SL; Pikal MJ
J Pharm Sci; 2008 Oct; 97(10):4498-515. PubMed ID: 18271035
[TBL] [Abstract][Full Text] [Related]
4. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2000 Mar; 89(3):408-16. PubMed ID: 10707020
[TBL] [Abstract][Full Text] [Related]
7. Role of α-relaxation on crystallization of amorphous celecoxib above T(g) probed by dielectric spectroscopy.
Dantuluri AK; Amin A; Puri V; Bansal AK
Mol Pharm; 2011 Jun; 8(3):814-22. PubMed ID: 21534589
[TBL] [Abstract][Full Text] [Related]
8. Glass transition and enthalpy relaxation of amorphous lactose glass.
Haque MK; Kawai K; Suzuki T
Carbohydr Res; 2006 Aug; 341(11):1884-9. PubMed ID: 16709405
[TBL] [Abstract][Full Text] [Related]
9. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.
Hancock BC; Shamblin SL; Zografi G
Pharm Res; 1995 Jun; 12(6):799-806. PubMed ID: 7667182
[TBL] [Abstract][Full Text] [Related]
10. A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses.
Zhou D; Grant DJ; Zhang GG; Law D; Schmitt EA
J Pharm Sci; 2007 Jan; 96(1):71-83. PubMed ID: 17031846
[TBL] [Abstract][Full Text] [Related]
11. Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP.
Caron V; Bhugra C; Pikal MJ
J Pharm Sci; 2010 Sep; 99(9):3887-900. PubMed ID: 20575050
[TBL] [Abstract][Full Text] [Related]
12. Molecular mobility as an effective predictor of the physical stability of amorphous trehalose.
Bhardwaj SP; Suryanarayanan R
Mol Pharm; 2012 Nov; 9(11):3209-17. PubMed ID: 23003337
[TBL] [Abstract][Full Text] [Related]
13. Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.
Mao C; Chamarthy SP; Pinal R
Pharm Res; 2006 Aug; 23(8):1906-17. PubMed ID: 16858653
[TBL] [Abstract][Full Text] [Related]
14. Coupling between chemical reactivity and structural relaxation in pharmaceutical glasses.
Shamblin SL; Hancock BC; Pikal MJ
Pharm Res; 2006 Oct; 23(10):2254-68. PubMed ID: 16941232
[TBL] [Abstract][Full Text] [Related]
15. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
[TBL] [Abstract][Full Text] [Related]
16. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
Yoshioka M; Hancock BC; Zografi G
J Pharm Sci; 1994 Dec; 83(12):1700-5. PubMed ID: 7891297
[TBL] [Abstract][Full Text] [Related]
17. Correlation between molecular mobility and physical stability of amorphous itraconazole.
Bhardwaj SP; Arora KK; Kwong E; Templeton A; Clas SD; Suryanarayanan R
Mol Pharm; 2013 Feb; 10(2):694-700. PubMed ID: 23198856
[TBL] [Abstract][Full Text] [Related]
18. Molecular mobility in glass forming fananserine: a dielectric, NMR, and TMDSC investigation.
Carpentier L; Decressain R; De Gusseme A; Neves C; Descamps M
Pharm Res; 2006 Apr; 23(4):798-805. PubMed ID: 16575499
[TBL] [Abstract][Full Text] [Related]
19. Crystallization Propensity of Amorphous Pharmaceuticals: Kinetics and Thermodynamics.
Krishna Kumar NS; Suryanarayanan R
Mol Pharm; 2022 Feb; 19(2):472-483. PubMed ID: 34979803
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.
Qi S; Weuts I; De Cort S; Stokbroekx S; Leemans R; Reading M; Belton P; Craig DQ
J Pharm Sci; 2010 Jan; 99(1):196-208. PubMed ID: 19492312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
